HOXD13 and endometrial cancer: 3.6. Concentration of the Soluble Form of PD-1 (sPD-1), PD-L1 (sPD-L1), PD-L2 (sPD-L2) in Plasma of Endometrial Cancer Patients, the Control Group, and the Reference Group